On Tuesday, Duke Energy Corp (NYSE:DUK)’s shares declined -1.28% to $69.15.
Duke Energy’s board of directors declared the appointment of former Comcast Corp. vice chairman and chief financial officer Michael Angelakis as a new board member, effective Oct. 1, 2015.
Angelakis presently is a senior advisor to Comcast’s executive administration committee and deputy chairman of the board for the Federal Reserve Bank of Philadelphia. He also serves as a Babson College trustee.
He soon will be chairman and chief executive officer of a new planned company he’s forming, in partnership with Comcast, that will focus on investing in and operating growth-oriented companies, domestically and internationally.
Angelakis served as Comcast’s vice chairman and CFO from 2007 to July 2015, overseeing the global media and technology company’s planned planning, corporate development, investor relations, taxation, and internal and external reporting units.
Duke Energy Corporation, together with its auxiliaries, operates as an energy company in the United States and Latin America. It operates through three segments: Regulated Utilities, International Energy, and Commercial Power. The Regulated Utilities segment generates, transmits, distributes, and sells electricity in the Carolinas, Florida, Ohio, Kentucky, and Indiana; and transports and sells natural gas in southwestern Ohio and northern Kentucky.
Amicus Therapeutics, Inc. (NASDAQ:FOLD)’s shares dropped -4.84% to $15.33.
Amicus Therapeutics (FOLD), a biotechnology company at the forefront of rare and orphan diseases, recently declared that John F. Crowley, Chairman and Chief Executive Officer, will present a corporate overview at the LEERINK Partners 4th Annual Rare Disease Roundtable in New York, NY on Wednesday, September 30, 2015 at 2:45 p.m. ET.
Amicus Therapeutics, Inc., a biopharmaceutical company, develops and commercializes therapeutic products for rare and orphan diseases. Its product candidate is a small molecule that can be used as a monotherapy and in combination with enzyme replacement therapy (ERT) for Fabry disease.
At the end of Tuesday’s trade, Parsley Energy Inc (NYSE:PE)‘s shares dipped -1.83% to $15.56.
Parsley Energy, Inc. (PE) declared that it has commenced an underwritten public offering of 13,000,000 shares of Class A common stock. The Company anticipates to grant the underwriter an option to purchase up to an additional 1,950,000 shares of Class A common stock from the Company. Net proceeds from the offering are predictable to be used to repay borrowings outstanding under the Company’s revolving credit facility and to fund a portion of its capital program, which may comprise acquisitions.
Goldman, Sachs & Co. is acting as a book-running manager for the offering.
Parsley Energy, Inc., an independent oil and natural gas company, engages in the acquisition, development, production, exploration, and sale of crude oil and natural gas properties in the Permian Basin located in West Texas and Southeastern New Mexico.
Douglas Emmett, Inc. (NYSE:DEI), ended its Tuesday’s trading session with -1.64% loss, and closed at $29.45.
Douglas Emmett, Inc. (DEI), a real estate investment trust (REIT), declared that its Board of Directors has declared a quarterly cash dividend on each share of its common stock of $0.21, or $0.84 on an annualized basis. The dividend will be paid on October 15, 2015 to shareholders of record as of September 30, 2015.
Douglas Emmett, Inc., a real estate investment trust, owns and operates office and multifamily properties in California and Hawaii. As of December 31, 2007, the company’s office portfolio comprised of 48 properties and multifamily portfolio comprised of 9 properties.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
